On 31 March 2015
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 31 March 2015, to consider allotment of equity shares / warrants as approved in the EGM dated 11 March 2015 on preferential basis subject to receiving relevant approval from Exchanges.Powered by Capital Market - Live News